Diopsys, Inc. was founded to become the leading provider of non-invasive medical devices that screen for visual disorders in infants and pre-school children. The technology by which we do this is known as "Visual Evoked Potential", or VEP.
The technology that powers the Enfant vision screening device was originally developed in 1983 by The Rockefeller University Laboratory of Biophysics. The technology was licensed to NeuroScientific Corporation, which in 1986, merged with Neurotech Corporation, a small publicly traded company. At Neurotech, the technology was updated and enhanced. The first systems created were the Venus and the Enfant and they were sold worldwide to large research institutions, teaching universities and large clinical practices. Many of these systems are still in use today.
